In continuation to the Exchange’s notice no. 20190228-47 dated Thursday, February 28th, 2019 Trading Members of the Exchange are hereby informed to take note of the following changes:
Company to be retained in ‘B’ group.
|
Sr.no
|
Scrip code
|
Company name
|
|
1
|
532960
|
Indiabulls Ventures Ltd
|
Company to be moved from ‘B’ group to ‘A’ group.
|
Sr.no
|
Scrip code
|
Company name
|
|
1
|
506820
|
AstraZeneca Pharm India
|
No other changes in aforesaid notice.
Mangesh Tayde
Senior Manager –Listing Operations (CRD)
March 05,2019
|